Nov 24, 2021

News provided by Share this article Share this article As per DelveInsight Analysis for Neurovascular Devices market, the increasing prevalence of neurological conditions, rising demands for minimally-invasive procedures are some of the key factors, which are expected to increase the overall demand for Neurovascular Devices, thus driving the growth of the Neurovascular Devices market. LAS VEGAS, Nov. 24, 2021 /PRNewswire/ -- DelveInsight's Neurovascular Devices Market Insights and Forecast  report provides the current and forecast Neurovascular Devices Market, upcoming innovation in the devices, individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Neurovascular Devices Market. Some of the salient features from the Neurovascular Devices Market  report:  As per an analysis by DelveInsight, North America is expected to dominate the overall Neurovascular Devices Market during the forecast period. Major pharma players working proactively in the Neurovascular Devices Market include Johnson & Johnson, Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corp., and others. DelveInsight estimates that the Global Neurovascular Devices/ Interventional Neurology Market was valued at USD 2.63 billion in 2020, growing at a CAGR of 8.10% during the forecast period from 2021 to 2026, to reach USD 3.98 billion. On April 21, 2021, Medtronic had received the FDA approval for Pipeline Flex Embolization Device with Shield Technology. On January 07, 2019, Terumo Corporation had announced that FDA had granted the Premarket Approval for the novel Intrasaccular Aneurysm Treatment Device for the treatment of intracranial wide-neck bifurcation aneurysms. To pick on the latest highlights related to Neurovascular Devices Market, get the snapshot of the key highlights entailed in the Neurovascular Devices Market  report. Neurovascular Devices/Interventional Neurology devices are devices that comprise coils, stents, clot-retrieving devices and other devices for the treatment of neurovascular disorders such as brain aneurysms and neurovascular thrombectomy. Clot retrieval devices, suction and aspiration devices are used in the removal of blood clots from the arteries and veins of the brain that can also lead to stroke. Neurovascular devices are used for the treatment of disorders that are associated with the blood vessels that carry oxygen-rich blood to the brain region. Interested in knowing how the Neurovascular Devices Market will be growing by 2026? Click to get a snapshot of  Neurovascular Devices Market Analysis Geographically, the global Neurovascular Devices market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue share North America currently leads the global market and is expected that it will remain constant during the forecast period. This domination in North America is observed majorly due to the growing cases of neurological disorders in the United States that require treatment through Neurovascular Devices. Owing to the growing patient population suffering from chronic neurological disorders and the launch and approval of embolization devices in various countries, there is an anticipated growth boost for the Neurovascular Devices market. For instance, on April 14, 2020, Keystone Heart Ltd. had announced that their cerebral embolic protection device, named TRIGUARD 3 had been granted the CE Mark approval. Also, on October 21, 2019, Shape Memory Medical had announced that they had received CE Mark approval for the Trellix embolic coil system. On May 07, 2019, Rapid Medical had announced the Food and Drug Administration approval of the novel Temporary Aneurysm Embolization Assist Device, Comaneci, a new category of temporary coil embolization assists devices. An increase in the prevalence rate of brain aneurysms suffering population, market development related to products and expansions, and the launch as well as approval of new innovative devices will lead to an increased demand for embolization devices, further leading to an increase in the Neurovascular Devices market growth. Apart from that rising incidence of hypertension across the globe leading to brain aneurysms may also lead to significant growth of the Neurovascular Devices market. The demand for Neurovascular Devices is primarily affected by the outbreak of the COVID-19 pandemic because of the delay in elective surgeries. Undiagnosed and unreported brain aneurysm cases also act as setbacks for the Neurovascular Devices market. To get a deeper understanding of the driving factors related to the Neurovascular Devices Market, get a snapshot of the  Neurovascular Devices Market Dynamics Study Period: 2018-2026 Neurovascular Devices Market Segmentation Understand the Competition, Risk Assessment and effective Research and Development  approach to take value-based decisions. Related Reports "Choroidal Neovascularization Pipeline Insights, 2021" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Choroidal Neovascularization market. A detailed picture of the Choroidal Neovascularization pipeline landscape is provided, which includes the disease overview, treatment guidelines, and key companies involved such as Johnson & Johnson, Medtronic, Stryker, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Kaneka Corp, and others. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market was valued at USD 681.36 million in 2020, growing at a CAGR of 6.11% during the forecast period from 2021 to 2026 to reach USD 969.17 million by 2026. The report delivers an in-depth understanding of Neurovascular Thrombectomy Devices and the historical and forecasted Neurovascular Thrombectomy Devices market trends, market drivers, market barriers and key companies involved such as Stryker, Penumbra, Vesalio, Acandis GmbH, Rapid Medical, Johnson & Johnson, Teleflex Incorporated, Medtronic, NeuroVasc Technologies, Inc., Perflow Medical, Edward LifeSciences Corporation, and many others. DelveInsight's 'Neurovascular Coiling Assist Devices -Market Insights, Competitive Landscape and Market Forecast - 2025' report delivers an in-depth understanding of Neurovascular Coiling Assist Devices and the historical and forecasted Neurovascular Coiling Assist Devices market trends, market drivers, market barriers and key companies involved such as Acandis GmBH, BALT Extrusion, Johnson & Johnson (Cerenovus), Medtronic Plc, Stryker, Terumo (MicroVention), and others. DelveInsight's 'Peripheral Vascular Clot Management Interventions Market Insights, Competitive Landscape and Market Forecast-2026' report delivers an in-depth understanding of peripheral vascular clot management interventions and the historical and forecasted peripheral vascular clot management interventions market trends, market drivers, market barriers and key companies involved such as Boston Scientific Corporation, Penumbra Inc, Medtronic, Koninklijke Philips N.V., Edward LifeSciences Corporation, Cardinal Health, Argon Medical Devices, Inc., Control Medical Technology, B. Braun Melsungen AG., Inari Medical, and others. Global Nerve Monitoring Systems Market was valued at USD 1.23 billion in 2020, growing at a CAGR of 4.17% during the forecast period from 2021 to 2026, to reach USD 1.72 billion by 2026. The report delivers an in-depth understanding of Nerve Monitoring Systems and the historical and forecasted Nerve Monitoring Systems market trends, market drivers, market barriers and key companies involved such as Medtronic PLC, Nihon Kohden Corporation, Natus Medical Incorporated, Innopsys Inc, Neurovision Medical Products, NeuroWave Systems Inc, Cadwell Industries, Dr. Langer Medical GmbH, Inomed Medizintechnik GmbH, Symmetry Surgical, Checkpoint Surgical Inc, and many others. Global Vascular Access Devices Market was valued at USD 4.31 billion in 2020, growing at a CAGR of 6.64% during the forecast period from 2021 to 2026, to reach USD 6.13 billion by 2026. The report delivers an in-depth understanding of Vascular Access Devices and the historical and forecasted Vascular Access Devices market trends, market drivers, market barriers and key companies involved such as  Becton, Dickinson, and Company, Teleflex Incorporated, Medtronic PLC, Zoll Medical Corporation, B Braun Melsungen AG, Prodimed, Amecath Medical Technologies, Terumo Medical Corporation, AngioDynamics, Edwards Lifesciences Corporation, C. R. Bard, Smiths Group PLC, Nipro Medical Corporation, and many others. DelveInsight's 'Neurovascular Catheters Devices - Market Insight, Competitive Landscape and Market Forecast, 2026' report delivers an in-depth understanding of Neurovascular Catheters Devices and the historical and forecasted Neurovascular Catheters Devices market trends. Neurovascular Catheters Devices market will be covered in-depth in the report comprising of company overview, financial overview, product overview and company share analysis of key players. Browse Through Our Blog Posts